MIRM — Mirum Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $5.61bn
- $5.92bn
- $521.31m
U.S. STOCKS ON THE MOVE -Fervo, Sensata Technologies, Akamai
U.S. STOCKS ON THE MOVE-Chipmakers, Dynatrace, Alibaba
Mirum Pharma dips on $600 mln convertible bond sale
Brief: Mirum Pharmaceuticals Prices $600.0 Million Convertible Senior Notes Offering
Brief: Mirum Pharmaceuticals Announces Proposed Convertible Senior Notes Offering
Mirum Pharma drops on announcing $600 mln convertible debt deal
Mirum Pharmaceuticals raises 2026 net product sales outlook
U.S. STOCKS ON THE MOVE-Mirum Pharma
U.S. STOCKS ON THE MOVE-Mirum Pharma, eBay, FedEx
Mirum Pharma rises after liver disease drug meets main goal in trial
Mirum's rare liver disease drug meets main goal in mid-stage study
Brief: Mirum Pharmaceuticals Announces Primary Endpoint Met In Vistas Study Of Volixibat In Patients With Primary Sclerosing Cholangitis
Brief: Mirum Pharmaceuticals Announces Primary Endpoint Met In Phase 2B Portion Of The Azure-1 Study
Mirum Pharma rises as hepatitis delta drug hits main goal
Brief: Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Mirum Pharmaceuticals Completes Enrollment In Phase 3 Expand Study Of Livmarli® (Maralixibat) In Additional Rare Cholestatic Liver Diseases
Brief: Mirum Pharmaceuticals Provides Azure Clinical Program Update For Brelovitug In Chronic Hepatitis Delta Virus
U.S. STOCKS ON THE MOVE-AnaptysBio, Tesla, Intel
Mirum Pharma gains after Evercore raises PT on liver drugs potential